Trial results published in a recent article indicate that patients using tiotropium in the early stages of chronic obstructive pulmonary disease (COPD) had better lung function and a slower decline in ...

May 14, 2003 — Tiotropium is more effective than salmeterol for treating chronic obstructive pulmonary disease (COPD), according to the results of a study published in the May issue of Thorax. This ...

Please provide your email address to receive an email when new articles are posted on . Tiotropium used as an additional treatment to inhaled corticosteroids reduced airflow obstruction and improved ...

Please provide your email address to receive an email when new articles are posted on . Daily tiotropium via the HandiHaler device improved lung function but did not reduce frequency of exacerbations ...

BARCELONA, Spain — The risk for mortality in chronic obstructive pulmonary disease (COPD) patients being treated with tiotropium is the same whether the drug is delivered by the Respimat Soft Mist ...

In order to widen the narrowed airways in patients with chronic obstructive pulmonary disease (COPD), tiotropium bromide (tiotropium in brief) is one of the drugs available that can be prescribed for ...

Using bronchodilators early on in patients with chronic obstructive pulmonary disease (COPD) is increasingly understood to be an important therapeutic intervention to improve quality of life, inhibit ...

Asthma patients, who have recurring symptoms and exacerbations despite using the combination therapy of inhaled glucocorticoids and long acting beta-agonists (LABA), show significant improvement with ...

Boehringer Ingelheim announced results from its Phase 3 UniTinA-asthma trial program evaluating tiotropium in adults, adolescents, and pediatric patients with different severities of asthma who remain ...

GlaxoSmithKline and Innovia announced new data at the American Thoracic Society (ATS) 2016 International Conference regarding the safety and efficacy of Anoro Ellipta ...